Dadbot, Wifebot, Friendbot: The Future of Memorializing Avatars

Dadbot, Wifebot, Friendbot: The Future of Memorializing Avatars

In 2015, about a year before he was diagnosed with terminal lung cancer, John Vlahos posed for a picture with his son, James.

(Courtesy James Vlahos)


Keep Reading Keep Reading
James Vlahos
James Vlahos is the author of TALK TO ME: How Voice Computing Will Transform the Way that We Live, Work, and Think (Houghton Mifflin, March 26, 2019). Covering the business, technological, and cultural ramifications of the voice revolution, the book has been described by readers such as Wired editor-in-chief Nicholas Thompson as "brilliant and essential." Vlahos is also the creator the Dadbot, a conversation-making program that shares the personality and life story of his late father, and of an Alexa skill, The Voice Computing Book. Vlahos contributes to the New York Times Magazine, Wired, Popular Science, The Atlantic, and GQ.
Sexually Transmitted Infections are on the rise. This drug could stop them.

Cases of gonorrhea, chlamydia and syphilis soared last year, but researchers are finding that a drug known as doxy seems to reduce the number of infections.

Adobe Stock

Sexually transmitted infections (STIs) are surging across the U.S. to 2.5 million cases in 2021 according to preliminary data from the CDC. A new prevention and treatment strategy now in clinical trials may provide a way to get a handle on them.

It's easy to overlook the soaring rates of gonorrhea, chlamydia, and syphilis because most of those infections have few or no symptoms and can be identified only through testing. But left untreated, they can lead to serious damage to nerves and tissue, resulting in infertility, blindness, and dementia. Infants developing in utero are particularly vulnerable.

Keep Reading Keep Reading
Bob Roehr
Bob Roehr is a biomedical journalist based in Washington, DC. Over the last twenty-five years he has written extensively for The BMJ, Scientific American, PNAS, Proto, and myriad other publications. He is primarily interested in HIV, infectious disease, immunology, and how growing knowledge of the microbiome is changing our understanding of health and disease. He is working on a book about the ways the body can at least partially control HIV and how that has influenced (or not) the search for a treatment and cure.
The Friday Five: The plain solution to holiday stress?

In this week's Friday Five, research on how to improve your working memory, the plain old solution to stress, rise of the robot surgeon, tomato brain power, the gut connection to health after strokes - and more.

Adobe Stock

The Friday Five covers five stories in research that you may have missed this week. There are plenty of controversies and troubling ethical issues in science – and we get into many of them in our online magazine – but this news roundup focuses on scientific creativity and progress to give you a therapeutic dose of inspiration headed into the weekend.

Keep Reading Keep Reading
Matt Fuchs
Matt Fuchs is the host of the Making Sense of Science podcast and served previously as the editor-in-chief of Leaps.org. He writes as a contributor to the Washington Post, and his articles have also appeared in the New York Times, WIRED, Nautilus Magazine, Fortune Magazine and TIME Magazine. Follow him @fuchswriter.